SCHEMBL6151203

SCHEMBL6151203

Cc1cccc(-c2ccc(S(=O)(=O)Nc3onc(C)c3Br)cc2)c1-c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 20/20 0.75
EDNRB P24530 19/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6151751 0.88 EDNRB (0.69) EDNRAEDNRB
SCHEMBL6152492 0.88 EDNRA (0.80) EDNRAEDNRB
SCHEMBL6151520 0.86 EDNRB (1.00) EDNRAEDNRB
SCHEMBL6151616 0.85 EDNRB (0.75) EDNRAEDNRB
SCHEMBL6151196 0.85 EDNRA (0.75) EDNRAEDNRB
SCHEMBL27466198 0.84 EDNRB (0.81) EDNRAEDNRB
SCHEMBL27456257 0.84 EDNRB (0.73) EDNRAEDNRB
SCHEMBL6151493 0.82 EDNRB (0.77) EDNRAEDNRB
SCHEMBL6150782 0.81 EDNRB (0.66) EDNRAEDNRB
SCHEMBL7228721 0.81 EDNRA (1.00) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1498419-A1 Process for preparing alkali metal salts of hydrophobic sulfonamides ENCYSIVE PHARMACEUTICALS INC. (US) 2005-01-19 EP disclosed
EP-1498418-A1 Sulfonamides for treatment of endothelin-mediated disorders ENCYSIVE PHARMACEUTICALS INC. (US) 2005-01-19 EP disclosed
EP-1048657-A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 2000-11-02 EP disclosed